Human regulatory T cells lack the cyclophosphamide-extruding transporter ABCB1 and are more susceptible to cyclophosphamide-induced apoptosis (Q50449094)

From Wikidata

Jump to navigation Jump to search

scientific article published on 27 October 2014

Language	Label	Description	Also known as
English	Human regulatory T cells lack the cyclophosphamide-extruding transporter ABCB1 and are more susceptible to cyclophosphamide-induced apoptosis	scientific article published on 27 October 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25251877

Human regulatory T cells lack the cyclophosphamide-extruding transporter ABCB1 and are more susceptible to cyclophosphamide-induced apoptosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25251877

object named as

Marco Fischer

3

0 references

object named as

Sarah Dimeloe

1

0 references

author name string

Corina Frick

2

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25251877

Patrick M Gubser

4

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25251877

Leyla Razik

5

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25251877

Glenn R Bantug

6

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25251877

Morgane Ravon

7

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25251877

Anja Langenkamp

8

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25251877

Christoph Hess

9

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25251877

language of work or name

0 references

publication date

27 October 2014

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25251877

European Journal of Immunology

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25251877

44

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25251877

12

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25251877

3614-3620

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25251877

Multidrug-resistant transport activity protects oocytes from chemotherapeutic agents and changes during oocyte maturation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444879

21 January 2018

The siRNA targeted to mdr1b and mdr1a mRNAs in vivo sensitizes murine lymphosarcoma to chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444879

21 January 2018

Cyclophosphamide metabolite inducing apoptosis in RLS mouse lymphosarcoma cells is a substrate for P-glycoprotein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444879

21 January 2018

Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444879

21 January 2018

Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444879

21 January 2018

A distinct subset of self-renewing human memory CD8+ T cells survives cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444879

21 January 2018

Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444879

21 January 2018

Role of p-glycoprotein expression in predicting response to neoadjuvant chemotherapy in breast cancer--a prospective clinical study

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444879

21 January 2018

Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444879

21 January 2018

Effect of ABCB1 and ABCC3 polymorphisms on osteosarcoma survival after chemotherapy: a pharmacogenetic study

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444879

21 January 2018

Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444879

21 January 2018

Immunogenic chemotherapy with cyclophosphamide and doxorubicin against established murine carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444879

21 January 2018

Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444879

21 January 2018

Immunological effects of low-dose cyclophosphamide in cancer patients treated with oncolytic adenovirus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444879

21 January 2018

Mitotracker green is a P-glycoprotein substrate

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444879

21 January 2018

ABCB1 transporter discriminates human resting naive B cells from cycling transitional and memory B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444879

21 January 2018

Human CD4+CD25+ regulatory T cells are sensitive to low dose cyclophosphamide: implications for the immune response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444879

21 January 2018

Selective depletion of CD4+CD25+Foxp3+ regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP levels

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444879

21 January 2018

Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444879

21 January 2018

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444879

21 January 2018

Increase of CD4+ CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+ CD25+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444879

21 January 2018

Multidrug-resistance phenotype of a subpopulation of T-lymphocytes without drug selection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444879

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444879

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/EJI.201444879

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25251877

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25251877

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50449094&oldid=2249531685"